Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ADAM T HUGHSTON

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1447647805
CMS profile
5700183
Location
LUBBOCK, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$2,400.50

133 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,400.50 133

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ADAM T HUGHSTON

NPI 1447647805 · CMS profile ID 5700183

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

LUBBOCK, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1447647805?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ADAM T HUGHSTON, NPI 1447647805, CMS profile ID 5700183. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1447647805?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). ADAM T HUGHSTON, NPI 1447647805, CMS profile ID 5700183. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1447647805?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
ADAM T HUGHSTON, NPI 1447647805, CMS profile ID 5700183, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 133 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1447647805?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

133 matching records · $2,400.50 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 133 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 133.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Mallinckrodt Hospital Products Inc. $21.3608/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211971400 CMS
Madrigal Pharmaceuticals $19.2607/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248270912 CMS
Ipsen Biopharmaceuticals, Inc $20.6207/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208847125 CMS
Aimmune Therapeutics, Inc. $1.7507/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249688316 CMS
Aimmune Therapeutics, Inc. $23.7807/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249688346 CMS
ABBVIE INC. $25.7207/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079417 CMS
ABBVIE INC. $13.6707/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079415 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.5807/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223893099 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.0907/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223874962 CMS
Madrigal Pharmaceuticals $21.0407/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248270909 CMS
ABBVIE INC. $26.8307/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079413 CMS
Janssen Biotech, Inc. $30.6807/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175095741 CMS
Madrigal Pharmaceuticals $19.3906/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248270906 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.4406/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223898967 CMS
ABBVIE INC. $28.3606/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079411 CMS
Aimmune Therapeutics, Inc. $16.7406/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249688334 CMS
ABBVIE INC. $20.3506/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079409 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.4706/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231780043 CMS
Phathom Pharmaceuticals, Inc. $12.4506/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219340118 CMS
ABBVIE INC. $19.3405/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079407 CMS
Janssen Biotech, Inc. $25.7305/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175094945 CMS
ABBVIE INC. $15.0105/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079405 CMS
Ipsen Biopharmaceuticals, Inc $15.9505/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208847123 CMS
PFIZER INC. $16.8605/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228891284 CMS
ABBVIE INC. $8.1805/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079403 CMS
ABBVIE INC. $14.5205/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079401 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.7405/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223863853 CMS
QOL Medical, LLC $34.2205/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184996280 CMS
ABBVIE INC. $26.6705/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079399 CMS
Janssen Biotech, Inc. $4.8804/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175096535 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.3404/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231780034 CMS
Ipsen Biopharmaceuticals, Inc $21.9804/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208847121 CMS
ABBVIE INC. $19.7304/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079397 CMS
Mallinckrodt Hospital Products Inc. $14.1304/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211971398 CMS
Madrigal Pharmaceuticals $17.1304/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248270903 CMS
ABBVIE INC. $15.6204/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079395 CMS
ABBVIE INC. $11.7004/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079393 CMS
Janssen Biotech, Inc. $4.1504/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175094832 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.3504/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223835400 CMS
Aimmune Therapeutics, Inc. $16.7404/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249688332 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.1404/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231780026 CMS
Phathom Pharmaceuticals, Inc. $11.7904/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219340112 CMS
Regeneron Healthcare Solutions, Inc. $22.2303/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212946573 CMS
ABBVIE INC. $25.0503/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079391 CMS
ABBVIE INC. $21.1503/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202079389 CMS
Janssen Scientific Affairs, LLC $96.3103/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174199129 CMS
Janssen Biotech, Inc. $20.2003/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175094370 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.3903/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231780017 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1.0203/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223796840 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.8703/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223856161 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $222.97 4
PY2021 $872.87 32
PY2022 $1,703.45 101
PY2023 $1,711.04 104
PY2024 $2,250.62 125
PY2025 $2,400.50 133

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $64.26 1
PY2025 Principal investigator $75,542.30 15
PY2024 Principal investigator $79,136.64 6
PY2023 Principal investigator $114,255.23 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

16 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $5,462.80 12/04/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONS PLLC
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn s Disease No dispute reported 06/30/2026 1202526626
Principal investigator 1 ABBVIE INC. $3,600.00 11/20/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONS PLLC
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn s Disease No dispute reported 06/30/2026 1202524830
Principal investigator 1 ABBVIE INC. $3,850.00 11/14/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONS PLLC
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn s Disease No dispute reported 06/30/2026 1202524361
Recipient Eli Lilly and Company $64.26 10/29/2025 Covered Recipient Physician A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED STUDY OF LY4268989 (MORF-057) CO-ADMINISTERED WITH MIRIKIZUMAB IN ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS No dispute reported 06/30/2026 1187871637
Principal investigator 1 Genentech, Inc. $17,000.00 10/29/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211663359
Principal investigator 1 ABBVIE INC. $2,696.40 09/04/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONS PLLC
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn s Disease No dispute reported 06/30/2026 1202508852
Principal investigator 1 ABBVIE INC. $5,952.80 08/06/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONS PLLC
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn s Disease No dispute reported 06/30/2026 1202503121
Principal investigator 1 ABBVIE INC. $6,638.80 07/02/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONS PLLC
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn s Disease No dispute reported 06/30/2026 1202495851
Principal investigator 1 Genentech, Inc. $6,716.00 06/18/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211663274
Principal investigator 1 ABBVIE INC. $6,925.80 06/17/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONS PLLC
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn s Disease No dispute reported 06/30/2026 1202491745
Principal investigator 1 Genentech, Inc. $3,768.00 03/21/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211663069
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $133.70 01/27/2025 Non-covered Recipient Entity
Lubbock Digestive Disease Associates
An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice No dispute reported 06/30/2026 1235996143
Principal investigator 1 Genentech, Inc. $2,158.00 01/22/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS PLLCD B A GI ALLIANCE
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211663533
Principal investigator 1 Genentech, Inc. $1,707.00 01/14/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS PLLCD B A GI ALLIANCE
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211663559
Principal investigator 1 Genentech, Inc. $97.00 01/13/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS PLLCD B A GI ALLIANCE
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211663536
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $8,836.00 01/10/2025 Non-covered Recipient Entity
Texas Digestive Disease Consultants Southlake
An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice No dispute reported 06/30/2026 1235993319

Ownership and Investment Interests

One row per program year and measure, newest year first · the amount invested and the value of the interest are never added together

Program yearMeasureAmountRecords
PY2024 Amount invested $5,914.25 1
PY2024 Value of interest $5,914.25 1
PY2023 Amount invested $5,914.25 1
PY2023 Value of interest $5,914.25 1

Ownership and Investment Interests are a separate CMS dataset, shown here separately and never added to payments.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

Ownership and Investment Interests records

Ordering applied by this site (program year, newest first, then company) · record values are shown as CMS published them

2 records · PY2023–2024

Ownership and Investment Interests records (CSV)

Program yearCompanyAmount invested Value of interestTerms of interestInterest held by Dispute statusPublishedRecord ID
PY2024 GastroGPO, LLC $5,914.25 $5,914.25 Common Stock Physician Covered Recipient No dispute reported 06/30/2026 1124819064
PY2023 GastroGPO, LLC $5,914.25 $5,914.25 Common Stock Physician Covered Recipient No dispute reported 06/30/2026 1050730025